IMO there are several reasons. One is that SAVA, which has a higher market cap, released good news. BTW, they are years behind Anavex in trials. SAVA’s drug has similar action to A2-73 but it supposedly helps AFTER proteins have already miss folded. AVXL’s action is to keep proteins from miss folding to begin with.
We’ve talked about how the chart is making cup with handle formations and higher lows.
Also AVXL’s stock price has been so held back that it should be much higher. A very big Thank You to the shorts ....... for holding this back so I could buy as much as I have,
Fletch